| Product Code: ETC9940759 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Choroidal Neovascularization Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Choroidal Neovascularization Market - Industry Life Cycle |
3.4 United Kingdom (UK) Choroidal Neovascularization Market - Porter's Five Forces |
3.5 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume Share, By Type of Diagnosis, 2021 & 2031F |
3.8 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume Share, By Type, 2021 & 2031F |
4 United Kingdom (UK) Choroidal Neovascularization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in the UK population |
4.2.2 Advancements in diagnostic technologies for early detection of choroidal neovascularization |
4.2.3 Growth in research and development activities focusing on innovative treatment options |
4.3 Market Restraints |
4.3.1 High treatment costs associated with choroidal neovascularization therapies |
4.3.2 Limited awareness among the general population about the condition and available treatment options |
4.3.3 Regulatory challenges and approval process for new drugs in the UK market |
5 United Kingdom (UK) Choroidal Neovascularization Market Trends |
6 United Kingdom (UK) Choroidal Neovascularization Market, By Types |
6.1 United Kingdom (UK) Choroidal Neovascularization Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Extreme Myopia, 2021- 2031F |
6.1.4 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Malignant Myopic Degeneration, 2021- 2031F |
6.1.5 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Age-Related Developments, 2021- 2031F |
6.2 United Kingdom (UK) Choroidal Neovascularization Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Extreme Myopia, 2021- 2031F |
6.2.3 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Malignant Myopic Degeneration, 2021- 2031F |
6.2.4 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Age-Related Developments, 2021- 2031F |
6.3 United Kingdom (UK) Choroidal Neovascularization Market, By Type of Diagnosis |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Fluorescein Angiography (FA), 2021- 2031F |
6.3.3 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Indocyanine Green (ICG) Angiography, 2021- 2031F |
6.3.4 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Spectral Domain Optical Coherence Tomography (OCT), 2021- 2031F |
6.3.5 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Choroidal Neovascularization Market, By Type |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 United Kingdom (UK) Choroidal Neovascularization Market Revenues & Volume, By Intravitreal, 2021- 2031F |
7 United Kingdom (UK) Choroidal Neovascularization Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Choroidal Neovascularization Market Export to Major Countries |
7.2 United Kingdom (UK) Choroidal Neovascularization Market Imports from Major Countries |
8 United Kingdom (UK) Choroidal Neovascularization Market Key Performance Indicators |
8.1 Patient engagement and education initiatives |
8.2 Adoption rates of new diagnostic technologies in clinical practice |
8.3 Success rates of clinical trials for novel choroidal neovascularization treatments |
9 United Kingdom (UK) Choroidal Neovascularization Market - Opportunity Assessment |
9.1 United Kingdom (UK) Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United Kingdom (UK) Choroidal Neovascularization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United Kingdom (UK) Choroidal Neovascularization Market Opportunity Assessment, By Type of Diagnosis, 2021 & 2031F |
9.4 United Kingdom (UK) Choroidal Neovascularization Market Opportunity Assessment, By Type, 2021 & 2031F |
10 United Kingdom (UK) Choroidal Neovascularization Market - Competitive Landscape |
10.1 United Kingdom (UK) Choroidal Neovascularization Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Choroidal Neovascularization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here